A double-blind, randomized controlled trial of gabapentin vs placebo for acute pain management in critically ill patients with rib fractures
Injury Jun 15, 2018
Moskowitz EE, et al. - In view of the efficacy of gabapentin following elective thoracic procedures, researchers tested if gabapentin, as compared to placebo, would both improve acute pain control and decrease narcotic use among critically ill patients with rib fractures. Forty patients admitted to the trauma surgery service from November 2016 – November 2017 at an urban, Level I trauma center with one or more rib fractures were randomized to either gabapentin 300 mg thrice daily or placebo for one month following their injury. Results showed no improved acute outcomes with gabapentin for up to one month of treatment in this group of critically ill patients with rib fractures.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries